Bone marrow-derived clonal mesenchymal stem cells as a source of cell therapy for promoting vocal fold wound healing

Annals of Otology, Rhinology and Laryngology

Volumn 122, Issue 2, 2013, Pages 121-130

  Kim, Young Mo ^a   Yi, Tac Ghee ^a   Choi, Jeong Seok ^a   Lee, Songyi ^a   Jang, Yun Ho ^a   Kim, Chul Ho ^b   Song, Sun U ^a   Lim, Jae Yol ^a  

^a Inha University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Clonal stem cell; Mesenchymal stem cell; Scarring; Stem cell transplantation; Vocal fold; Wound healing

Indexed keywords

COLLAGEN; FIBRONECTIN; GLYCOSAMINOGLYCAN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL THERAPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXPERIMENTAL RABBIT; FRACTIONATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LARYNX INJURY; MESENCHYMAL STEM CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VISCOELASTICITY; VOCAL CORD; WOUND HEALING; XENOGRAFT; XENOTRANSPLANTATION;

EID: 84873647955     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941312200208     Document Type: Article

References (26)

1. Benninger MS, Alessi D, Archer S, et al.. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-82.
2. Long JL. Tissue engineering for treatment of vocal fold scar. Curr Opin Otolaryngol Head Neck Surg 2010;18:521-5.
3. Kutty JK, Webb K. Tissue engineering therapies for the vocal fold lamina propria. Tissue Eng Part B Rev 2009;15:249-62.
4. Hanson S, Thibeault SL, Hematti P. Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. Curr Stem Cell Res Ther 2010;5:268-72.
5. Pittenger MF, Mackay AM, Beck SC, et al.. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
6. Liechty KW, MacKenzie TC, Shaaban AF, et al.. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-6.
7. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 1996;11:312-24.
8. Clark BR, Keating A. Biology of bone marrow stroma. Ann N Y Acad Sci 1995;770:70-8.
9. Kanemaru S, Nakamura T, Omori K, et al.. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003;112:915-20.
10. Kanemaru S, Nakamura T, Yamashita M, et al.. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol 2005;114:907-12.
11. Hertegård S, Cedervall J, Svensson B, et al.. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope 2006;116:1248-54.
12. Svensson B, Nagubothu RS, Cedervall J, et al.. Injection of human mesenchymal stem cells improves healing of scarred vocal folds: analysis using a xenograft model. Laryngoscope 2010;120:1370-5.
13. Song SU, Kim CS, Yoon SP, et al.. Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion. Stem Cells Dev 2008;17:451-61.
14. Rousseau B, Hirano S, Chan RW, et al.. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004; 18:116-24.
15. Tateya T, Tateya I, Sohn JH, Bless DM. Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol 2005;114:183-91.
16. Rousseau B, Hirano S, Scheidt TD, et al.. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-7.
17. Kumai Y, Kobler JB, Park H, et al.. Crosstalk between adipose-derived stem/stromal cells and vocal fold fibroblasts in vitro. Laryngoscope 2009;119:799-805.
18. Johnson BQ, Fox R, Chen X, Thibeault S. Tissue regeneration of the vocal fold using bone marrow mesenchymal stem cells and synthetic extracellular matrix injections in rats. Laryngoscope 2010;120:537-45.
19. Ohno S, Hirano S, Kanemaru S, et al.. Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2011;120:401-8.
20. Ohno T, Hirano S, Rousseau B. Extracellular matrix gene expression during wound healing of the injured rat vocal fold. Otolaryngol Head Neck Surg 2009;140:757-61.
21. Rousseau B, Ge PJ, Ohno T, French LC, Thibeault SL. Extracellular matrix gene expression after vocal fold injury in a rabbit model. Ann Otol Rhinol Laryngol 2008;117:598-603.
22. Hirano S, Bless DM, Rousseau B, Welham N, Scheidt T, Ford CN. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 2003;113:966-72.
23. Ohno T, Hirano S, Rousseau B. Gene expression of transforming growth factor-β1 and hepatocyte growth factor during wound healing of injured rat vocal fold. Laryngoscope 2009; 119:806-10.
24. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648-59.
25. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2007;109:3147-51.
26. Ball L, Bredius R, Lankester A, et al.. Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versushost disease in a child with juvenile myelo-monocytic leukemia. Leukemia 2008;22:1256-7.